To champion a healthier world by preventing infections.
Q3: Continued profitability and clinical evidence supporting future growth
-
Revenue48.4 MSEK(73.9)
-
EBITDA5.3 MSEK(9.9)
-
Cash flow-2.8 MSEK(8.3)
Interim report Q3 2025
Bactiguard Holding AB (publ) published its interim report for the third quarter on Thursday 23 October 2025 at 07:00 CET.
In connection with this, Bactiguard will host an audiocast for investors, analysts, and media at 11:00 CET. CEO Christine Lind will present the report and answer questions together with CFO Patrick Bach.
Annual and Sustainability Report 2024
Updated strategic and financial targets
Bactiguard Holding AB (publ.) has announced its updated strategic and financial targets following a review announced in connection with the 2024 Q3 report. The updated targets reflect a sharpened strategic focus on the license business and EBITDA profitability, a transformation delivered in 2024.
The Bactiguard Technology
The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.
Purpose
Vision
To be the global standard of care for preventing medical device related infections.
Mission
To be the premier partner for leading MedTech companies, joining forces to redefine healthcare and improve health worldwide.
Core values
- Respect
- Trust
- Transparency
- Performance
Bactiguard is a purpose-driven company with a strong corporate culture, firmly anchored in four core values. The values are an integral part of Bactiguard’s purpose to champion a healthier world by preventing infections and a prerequisite to achieve our targets.
Bactiguard as an investment
The ambition is to become a profitable knowledge and specialist organization which is a prerequisite to deliver on our financial, strategic and sustainability targets.
-
07Jan 2026
Bactiguard presents at SEB Nordic Seminar
Copenhagen, Denmark -
05Feb 2026
Year-end report 1 January – 31 December 2025
-
11Mar 2026
Bactiguard presents at DNB Carnegie Nordic Healthcare Conference
Stockholm, Sweden
Media & Investor Relations
-
Patrick Bach
CFO
+46 (0) 76 129 59 11